For research use only. Not for therapeutic Use.
HCV-IN-29 is a hepatitis C virus (HCV) inhibitor exacted from patent US8329159B2, compound 1e[1].
Catalog Number | I045889 |
CAS Number | 1009119-83-8 |
Synonyms | 2-[(2S)-pyrrolidin-2-yl]-5-[4-[4-[2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazole;tetrahydrochloride |
Molecular Formula | C26H32Cl4N6 |
Purity | ≥95% |
InChI | InChI=1S/C26H28N6.4ClH/c1-3-21(27-13-1)25-29-15-23(31-25)19-9-5-17(6-10-19)18-7-11-20(12-8-18)24-16-30-26(32-24)22-4-2-14-28-22;;;;/h5-12,15-16,21-22,27-28H,1-4,13-14H2,(H,29,31)(H,30,32);4*1H/t21-,22-;;;;/m0..../s1 |
InChIKey | AYOXSBJGFNPGNK-VDUNKYASSA-N |
SMILES | C1CC(NC1)C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6.Cl.Cl.Cl.Cl |
Reference | [1]. Makonen Belema, et al. Hepatitis C virus inhibitors. US8329159B2. |